Medical News

RSS

Guatemalan Congress repeals law that restricted access to medicines

The Guatemalan Congress's repeal of a law that severely restricts people's access to affordable essential medicines is a positive step forward.

29 Nov 2004

New class of drugs to repair psychiatric disorders

“Smart” drugs capable of targeting specific brain cells to control psychiatric disorders such as autism and schizophrenia may be ready for early clinical trials within three years, with the launch of a $1.5 million project to take place at the Brain Research Centre (BRC)

29 Nov 2004

Computer program helps decode cancer

Researchers at the University of Newcastle, Australia have developed a computer program that implements a novel algorithm, which will aid in the identification of specific cancer causing genes.

29 Nov 2004

53,000 adults living with HIV/AIDS in the UK

There are now 53,000 adults living with HIV/AIDS in the UK, over a quarter of whom (14,300) remain unaware of their infection according to the Health Protection Agency's annual report on HIV.

29 Nov 2004

Scientists have induced human insulin-producing cells of the pancreas to revert to islet precursor cells

Scientists at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) have induced human insulin-producing cells of the pancreas to revert to islet precursor cells.

29 Nov 2004

Health risks of goat milk and derived products with regards to BSE/TSE

The Scientific Expert Working Group on BSE/TSE of the European Food Safety Authority’s (EFSA) Scientific Panel on Biological Hazards have published a statement on the safety of goat milk and milk products with regards to possible BSE/TSE risks.

29 Nov 2004

Elevated BMI may not increase risk of death among men with heart attack or stroke

BMI, or body mass index, is considered an indicator of both mortality and heart attack risk among middle-aged and older men free of major diseases. However, the impact of BMI on mortality in men who have already had a heart attack or stroke has not been clearly established.

29 Nov 2004

Fathers' genes play an equal part in the spread of eczema

Doctors have known for many years that eczema - also known as atopic dermatitis - runs in families. In the past, it was thought that if a baby suffered from eczema, it was more likely to have come from the mother's side.

29 Nov 2004

New virtual microscopy system

Researchers at the universities of Helsinki and Tampere (Finland) have developed a new virtual microscopy system, which allows users digitize entire microscope glass slide specimens, and then create a virtual slide with the quality and resolution similar to the original glass slide viewed on a microscope.

29 Nov 2004

New possibilities for the use of VEGF in the treatment of Amyotrophic Lateral Sclerosis

ALS is an incurable, paralyzing neurodegenerative disorder that strikes 5 persons in every 100,000. The disease commonly affects healthy people in the most active period of their lives − without warning or previous family history.

29 Nov 2004

Tougher action needed to stop cigarette sales to children

Retailers should be licensed to sell cigarettes, and the licence revoked if they are caught selling tobacco to children, the Australian Medical Association (WA) said today.

29 Nov 2004

Rigour and Vigour Conference: Directions in HIV Prevention

Curtin University of Technology, Australia, will host the Rigour and Vigour Conference: Directions in HIV Prevention tomorrow to coincide with World AIDS Day on Wednesday 1 December.

29 Nov 2004

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.

29 Nov 2004

British parents admit responsibility lies with them to tackle childhood obesity

More than 80% of parents say that they intend to be more accountable for their child's weight and four in five believe that measures set out in the Government's White Paper last week would go a long way to help them combat obesity in their children.

29 Nov 2004

Moldova making progress in fight against HIV/AIDS and tuberculosis

Moldova’s early actions to fight HIV/AIDS and tuberculosis are slowing the rise of the country’s dual tuberculosis and AIDS epidemics, the World Bank reports.

29 Nov 2004

Virtual colonoscopy raises issues for further study

The American Society for Gastrointestinal Endoscopy (ASGE) has reacted with caution to claims of the benefits of computed tomography (CT) colonography, also referred to as virtual colonoscopy, compared to standard colonoscopy.

29 Nov 2004

Effective management of insomnia begins with recognition and adequate assessment

A seminar in this week’s issue of THE LANCET outlines the common but poorly understood condition of insomnia, concluding that awareness and assessment of insomnia by family doctors is a priority.

29 Nov 2004

Drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria

Results of a randomised trial from Uganda in this week’s issue of THE LANCET suggest that the drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria in terms of efficacy and cost-effectiveness in this region.

29 Nov 2004

4 million extra health workers needed worldwide

Authors of a public-health article in this week’s issue of THE LANCET are calling for urgent international action to address the chronic lack of investment in human resources which is limiting the chance of tackling diseases such as HIV/AIDS, malaria, and TB.

29 Nov 2004

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

Forest Laboratories have announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), the first and only fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg), was approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute, moderate to severe pain.

29 Nov 2004